Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | MAOA | P21397 | 2/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.61 |
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | CES1 | P23141 | 1/20 | 0.55 |
| ▸ | NOS3 | P29474 | 2/20 | 0.52 |
| ▸ | DRD4 | P21917 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.44 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31430380 | 1.00 | TSHR (0.71) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL30668198 | 0.97 | TSHR (0.67) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL30436120 | 0.97 | TSHR (0.67) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL31135519 | 0.97 | TSHR (0.67) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL31621255 | 0.97 | TSHR (0.67) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL30731351 | 0.97 | TSHR (0.67) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL29593589 | 0.97 | TSHR (0.67) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL30505637 | 0.94 | CYP2A6 (0.68) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL3103992 | 0.94 | CYP2A6 (0.68) | TSHRMAOACYP2A6MAOBHPGD | |
| SCHEMBL30436320 | 0.91 | CYP2A6 (0.65) | TSHRMAOACYP2A6MAOBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119688896-B | Cell membrane bionic nano-recognition material and preparation method and application thereof | 陕西科技大学 | 2026-05-12 | — | — | CN | claimed |
| CN-119033823-B | Probiotic product and preparation method and application thereof | 南昌大学 | 2025-04-22 | — | — | CN | claimed |
| CN-119688896-A | Cell membrane bionic nano-recognition material and preparation method and application thereof | 陕西科技大学 | 2025-03-25 | — | — | CN | claimed |
| CN-119033823-A | Probiotic product and preparation method and application thereof | 南昌大学 | 2024-11-29 | — | — | CN | claimed |
| CN-118759172-A | Preparation method of allophycocyanin immunofluorescence probe | 宝天生物科技（上海）有限公司 | 2024-10-11 | — | — | CN | claimed |
| US-20240327322-A1 | Crosslinked Polymers with Tunable Coefficients of Thermal Expansion | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2024-10-03 | — | — | US | claimed |
| CN-117327262-B | Responsive nano-drug carrier and preparation and application thereof | 中山大学附属第三医院 | 2024-06-14 | — | — | CN | claimed |
| CN-117946419-A | Long-acting antibacterial carboxymethyl chitosan gel and preparation method and application thereof | 暨南大学 | 2024-04-30 | — | — | CN | claimed |
| US-20240096839-A1 | SEMICONDUCTOR PACKAGE | SAMSUNG ELECTRONICS CO. LTD. (KR) | 2024-03-21 | — | — | US | claimed |
| CN-114507335-B | High-performance epoxy resin with adjustable thermal expansion coefficient and preparation method thereof | 复旦大学 | 2024-03-08 | — | — | CN | claimed |
| US-20180315988-A1 | NEGATIVE THERMAL EXPANSION CURRENT INTERRUPTER | AMERICAN LITHIUM ENERGY CORPORATION | 2018-11-01 | — | — | US | claimed |
| WO-2007005760-A1 | METHODS OF APPLICATION OF CHEMICAL COMPOUNDS HAVING THERAPEUTIC ACTIVITIES IN TREATING CANCERS | WANG HAIBIN (US) | 2007-01-11 | — | — | WO | claimed |
| US-20050282910-A1 | Methods of application of chemical compounds having therapeutic activities in treating cancers | NINGBO INNOPHARMA TECHNOLOGIES, INC. (CN) | 2005-12-22 | — | — | US | claimed |
| EP-0828764-B1 | ADDITION POLYMERS OF POLYCYCLOOLEFINS CONTAINING FUNCTIONAL SUBSTITUENTS | GOODRICH CO B F (US) | 2000-09-06 | — | — | EP | claimed |
| US-5484595-A | Process for preparation of dibenzocyclooctadiene type lignan | TSUMURA & CO. (JP) | 1996-01-16 | — | — | US | claimed |
| EP-0606344-B1 | SOLID-FORM ADDITIVE SYSTEMS DISPERSIBLE IN AQUEOUS MEDIA AND METHOD FOR THEIR PREPARATION | EASTMAN CHEM CO (US) | 1996-01-03 | — | — | EP | claimed |
| EP-0389631-A1 | PROCESS FOR PREPARING DIBENZOCYCLOOCTADIENE TYPE LIGNAN | TSUMURA & CO. (JP) | 1990-10-03 | — | — | EP | claimed |
| EP-0259417-B1 | RUTHENIUM CATALYST FOR BIARYLIC COUPLING; NEW STEGANOLIDES | UNIVERSITE DU MAINE (LE MANS) (FR) | 1990-01-03 | — | — | EP | claimed |
| EP-0259417-A1 | RUTHENIUM CATALYST FOR BIARYLIC COUPLING; NEW STEGANOLIDES. | UNIV MAINE LE MANS (FR) | 1988-03-16 | — | — | EP | claimed |
| WO-1987005289-A1 | RUTHENIUM CATALYST FOR BIARYLIC COUPLING; NEW STEGANOLIDES | UNIVERSITE DU MAINE (LE MANS) (FR) | 1987-09-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282910-A1 | Methods of application of chemical compounds having therapeutic activities in treating cancers | ABCC1, ABCB1, ABCC2 | TSHR 3898/4885MAOA 2909/4885CYP2A6 1068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.